- 1. Lunate
- [A moon-shaped carpal bone which is located between the SCAPHOID BONE and TRIQUETRUM BONE. ( MSH )] (UMLS (NCI) C0036624) =Body Part, Organ, or Organ Component ;
| - 34. Lung Mass
- (UMLS (NCI) C0149726) =Finding
|
- 2. Lunate Sulcus
- (UMLS (NCI) C0262278) =Body Part, Organ, or Organ Component
| - 35. Lung Meningioma
- (UMLS (NCI) C1334450) Meningioma of Lung;
Meningioma of the Lung;
Pulmonary Meningioma =Neoplastic Process |
- 3. lung
- [either of the pair of organs occupying the lateral cavity of the thorax that effect the aeration of the blood. ( CSP )] (UMLS (CSP) C0024109) =Body Part, Organ, or Organ Component ;
=Body System, Pulmonary;
Body Part =lung alveolus | - 36. Lung Metastases
- [Cancer that has spread from the original (primary) tumor to the lung. ( NCI )] (UMLS (NCI) C0153676) =Neoplastic Process
|
- 4. Lung Adenocarcinoma Stage II
- [A non-small cell lung cancer (NSCLC), histologically classified as adenocarcinoma. No distant metastasis. Various extents of tumor size and aggressiveness, and of regional lymph node metastasis. Subclassified as Stage IIA (T1, N1, M0) or Stage IIB (either T2, N1, M0 or T3, N0, M0). N0: No regional lymph node metastasis. N1: Metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes including involvement by direct extension of the primary tumor. T1: Tumor is 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus. T2: Tumor has any of the following features of size or extent: More than 3 cm in greatest dimension; involves the main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: Tumor (of any size) directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, mediastinal pleura, parietal pericardium; or tumor in the main bronchus less than 2 cm distal to the carina but without involvement of the carina; or associated atelectasis or obstructive pneumonitis of the entire lung. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0854986) Lung Adenocarcinoma, Stage II;
Stage II Adenocarcinoma of Lung;
Stage II Adenocarcinoma of the Lung;
Stage II Lung Adenocarcinoma =Neoplastic Process | - 37. Lung Myolipoma
- [A benign tumor of the lung composed of mature adipocytes and smooth muscle cells. ( NCI )] (UMLS (NCI) C1334451) Myolipoma of Lung;
Myolipoma of the Lung;
Pulmonary Myolipoma =Neoplastic Process |
- 5. Lung Adenocarcinoma Stage III
- [A non-small cell lung cancer (NSCLC), histologically classified as adenocarcinoma. No distant metastasis. Various extents of tumor size and aggressiveness, and of regional lymph node metastasis. Subclassified as Stage IIIA (T1, N2, M0; T2, N2, M0; T3 ,N1, M0; T3 ,N2, M0) or Stage IIIB (Any T, N3, M0; T4, Any N, M0). N1: Metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes including involvement by direct extension of the primary tumor. N2: Metastasis to ipsilateral mediastinal and/or subcarinal lymph node(s). N3: Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s). T1: Tumor is 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, and without bronchoscopic evidence of invasion more proximal than the lobar bronchus. T2: Tumor has any of the following features of size or extent: more than 3 cm in greatest dimension; involves the main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: Tumor (of any size) directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, mediastinal pleura, parietal pericardium; or tumor in the main bronchus less than 2 cm distal to the carina but without involvement of the carina; or associated atelectasis or obstructive pneumonitis of the entire lung. T4: Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, carina; or separate tumor nodules in the same lobe; or tumor with a malignant pleural effusion. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0854987) Lung Adenocarcinoma, Stage III;
Stage III Adenocarcinoma of Lung;
Stage III Adenocarcinoma of the Lung;
Stage III Lung Adenocarcinoma =Neoplastic Process | - 38. lung neoplasm
- [new abnormal tissue of the lung that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease. ( CSP )] (UMLS (CSP) C0024121) =Neoplastic Process ;
=Lung Diseases;
Neoplasm of Respiratory Tract =bronchial cancer;
Carcinoma, Non-Small-Cell Lung;
Carcinoma, Small Cell;
bronchial cancer;
Coin Lesion, Pulmonary;
Pancoast Syndrome;
Blastoma of Lung |
- 6. Lung Adenocarcinoma, Recurrent
- [The re-emergence of lung adenocarcinoma after a period of remission. (NCI05) ( NCI )] (UMLS (NCI) C0854983) Recurrent Adenocarcinoma of Lung;
Recurrent Adenocarcinoma of the Lung;
Recurrent Lung Adenocarcinoma;
=Neoplastic Process | - 39. Lung Neuroendocrine Neoplasm
- (UMLS (NCI) C1334452) Lung Neuroendocrine Tumor;
Neuroendocrine Neoplasm of Lung;
Neuroendocrine Neoplasm of the Lung;
Neuroendocrine Tumor of Lung;
Neuroendocrine Tumor of the Lung;
Pulmonary Neuroendocrine Neoplasm;
Pulmonary Neuroendocrine Tumor =Neoplastic Process |
- 7. Lung Adenocarcinoma, Stage I
- [A non-small cell lung cancer (NSCLC), histologically classified as adenocarcinoma. No regional lymph node or distant metastases. Tumor size and aggressiveness vary. Subclassified as Stage IA (T1, N0, M0) or Stage IB (T2, N0, M0). T1: tumor is 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus, with neither regional lymph node nor distant metastases. T2: tumor has any of the following features of size or extent: more than 3 cm in greatest dimension; involves the main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0854985) Stage I Adenocarcinoma of Lung;
Stage I Adenocarcinoma of the Lung;
Stage I Lung Adenocarcinoma;
=Neoplastic Process | - 40. Lung Non-Hodgkin Lymphoma
- (UMLS (NCI) C1334453) Lung Non-Hodgkin's Lymphoma;
Primary Lung Non-Hodgkin's Lymphoma;
=Neoplastic Process |
- 8. Lung Adenocarcinoma, Stage IV
- [A non-small cell lung cancer (NSCLC), histologically classified as adenocarcinoma. Distant metastasis is present. Tumor can be of any size and aggressiveness, with any degree of regional lymph node metastasis (Any T, Any N, M1). (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0854988) Metastatic Adenocarcinoma of Lung;
Metastatic Adenocarcinoma of the Lung;
Metastatic Lung Adenocarcinoma;
Stage IV Adenocarcinoma of Lung;
Stage IV Adenocarcinoma of the Lung;
Stage IV Lung Adenocarcinoma =Neoplastic Process | - 41. Lung Non-Small Cell Carcinoma in situ
- [Stage 0 includes Tis,NO,MO. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. ( NCI )] (UMLS (NCI) C0278986) =Neoplastic Process
|
- 9. lung alveolus
- [small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place. ( CSP )] (UMLS (CSP) C0034051) =Body Part, Organ, or Organ Component ;
=lung;
| - 42. LUNG OPERATION NEC
- [ ] (UMLS (ICD9CM) C0176526) =Therapeutic or Preventive Procedure
|
- 10. lung cancer
- [A primary or metastatic malignant neoplasm involving the lung ( NCI )] (UMLS (CSP) C0242379) =Neoplastic Process ;
| - 43. Lung PAP-AD
- [A morphologic variant of lung adenocarcinoma characterized by the presence of papillary structures. (NCI05) ( NCI )] (UMLS (NCI) C1335325) Lung Papillary-Adenocarcinoma;
Papillary Adenocarcinoma of Lung;
Papillary Adenocarcinoma of the Lung;
Papillary Lung Adenocarcinoma;
=Neoplastic Process ;
|
- 11. Lung Cancer Antigen NY-LU-12
- [Widely expressed by human RBM6 Gene, 1,123-aa RNA Binding Motif Protein 6 contains 20 inexact 6-aa N-terminal repeats, 2 RNA-binding domains, 2 zinc finger motifs, nuclear localization signals, and specifically binds RNA. (NCI) ( NCI )] (UMLS (NCI) C0907883) Protein 3G2;
Protein G16;
RNA Binding Motif Protein 6;
RNA-Binding Protein 6;
RNA-Binding Protein DEF3;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 44. Lung Papilloma
- [A overgrowth of epithelial tissue in the respiratory tree. ( NCI )] (UMLS (NCI) C0281373) =Neoplastic Process ;
|
- 12. Lung Cancer Prevention
- (UMLS (NCI) C0281194) =Therapeutic or Preventive Procedure
| - 45. Lung Parenchyma
- [Tissue consisting of an external serous coat, subserous areolar tissue and lung parenchyma. The parenchyma is made up of lobules wound together by connective tissue. A primary lobule consists of a terminal bronchiole, respiratory bronchioles, and alveolar ducts, which communicate with many alveoli, each alveolus being surrounded by a network of capillary blood vessels. ( NCI )] (UMLS (NCI) C0819757) Lung Tissue =Tissue
|
- 13. Lung Carcinoma Metastatic to the Bone
- (UMLS (NCI) C1334440) =Neoplastic Process
| - 46. lung preservation
- [ ] (UMLS (CSP) C0599546) =Laboratory Procedure ;
|
- 14. Lung Carcinoma Metastatic to the Brain
- (UMLS (NCI) C1334441) =Neoplastic Process
| - 47. lung pressure
- [ ] (UMLS (CSP) C0599321) =Organ or Tissue Function ;
|
- 15. Lung Carcinoma Metastatic to the Liver
- (UMLS (NCI) C1334442) =Neoplastic Process
| - 48. LUNG REPAIR NEC
- [ ] (UMLS (ICD9CM) C0176521) =Therapeutic or Preventive Procedure
|
- 16. lung development
- [pulmonary development. ( CSP )] (UMLS (CSP) C1160389) =Organ or Tissue Function =Developmental Process, Multicellular;
| - 49. Lung replaced by transplant
- [ ] (UMLS (ICD9CM) C0543420) =Finding
|
- 17. lung function
- [physiological activity and functions of the respiratory system as a whole or of any of its parts, including any portion of the breathing process, the exchange of oxygen and carbon dioxide and internal (cellular) or external respiration (ventilation). ( CSP )] (UMLS (CSP) C0035245) =Organ or Tissue Function ;
=Physiology;
=pulmonary respiration;
respiratory airway volume;
exercise tolerance;
respiratory airway clearance;
respiratory airway pressure;
respiratory gas;
| - 50. Lung Right Upper Lobe
- (UMLS (NCI) C1261074) Upper Lobe of Right Lung -RUL;
Upper Lobe of the Right Lung;
Upper Lobe of the Right Lung -RUL =Body Part, Organ, or Organ Component |
- 18. lung grafting
- [transference of lung between individuals of the same species, or between individuals of different species. ( CSP )] (UMLS (NCI) C0024128) =Therapeutic or Preventive Procedure ;
=respiratory transplantation;
| - 51. Lung Sarcoidosis
- [Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431) ( MSH )] (UMLS (NCI) C0036205) =Disease or Syndrome ;
=Besnier Boeck disease;
ILD |
- 19. Lung Granuloma
- (UMLS (NCI) C0235557) =Neoplastic Process
| - 52. lung sarcoma
- [ ] (UMLS (CSP) C0598790) =Neoplastic Process ;
|
- 20. lung hypoxia
- [ ] (UMLS (CSP) C0599335) =Pathologic Function ;
| - 53. Lung Sclerosing Angioma
- [A benign neoplasm of alveolar pneumocytes or ontogenetically primitive counterparts thereof. Morphological patterns that have been described include: solid, hemorrhagic, papillary, and sclerotic. Most lesions display a combination of two or three morphological patterns. Despite the implication by its name (HEMANGIOMA) of a vascular neoplasm, pulmonary sclerosing hemangioma is considered by most authorities to be an epithelial tumor. (Histopathology 2003;43(3):239-43; Arch Pathol Lab Med. 2001;125(10): 1335-9) ( MSH )] (UMLS (NCI) C1334455) Lung Sclerosing Hemangioma;
Pneumocytoma;
Sclerosing Angioma of Lung;
Sclerosing Angioma of the Lung;
Sclerosing Hemangioma of Lung;
Sclerosing Hemangioma of the Lung;
=Neoplastic Process |
- 21. lung imaging
- [ ] (UMLS (CSP) C0203683) =Diagnostic Procedure
| - 54. Lung Solid Adenocarcinoma with Mucin
- [Amorphologic variant of lung adenocarcinoma characterized by a solid growth pattern and the presence of mucin producing neoplastic cells. (NCI05) ( NCI )] (UMLS (NCI) C1336026) Pulmonary Solid Adenocarcinoma with Mucin;
Solid Adenocarcinoma of Lung with Mucin;
Solid Adenocarcinoma of the Lung with Mucin;
Solid Carcinoma of Lung with Mucus Formation;
Solid Carcinoma of the Lung with Mucus Formation;
Solid Lung Adenocarcinoma with Mucin Production;
Solid Lung Carcinoma with Mucus Formation =Neoplastic Process ;
|
- 22. lung imaging/visualization/scanning
- [visual display of structural or functional patterns of the lungs or lung tissues for diagnostic evaluation or imaging of anatomical structures; includes measuring physiologic and metabolic responses to physical and chemical stimuli. ( CSP )] (UMLS (CSP) C0920365) =Diagnostic Procedure ;
=respiratory imaging/visualization;
| - 55. Lung Squamous Cell Carcinoma Stage II
- [Stage II includes: IIA: (T1, N1, M0); IIB: (T2, N2, M0); (T3, N0, M0). T2: Tumor with any of the following features of size or extent: More than 3cm in greatest dimension. Involves main bronchus, 2cm or more distal to the carina. Invades the visceral pleura. Associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: Tumor of any size that directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, mediastinal pleura, parietal pericardium; or tumor in the main bronchus less than 2cm distal to the carnia, but without involvement of the carnia; or associated atelectasis or obstructive pneumonitis of the entire lung. N0: No regional lymph node metastasis. N1: Metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes including involvement by direct extension of the primary tumor. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C0854992) Stage II Epidermoid Cell Carcinoma of Lung;
Stage II Epidermoid Cell Carcinoma of the Lung;
Stage II Epidermoid Cell Lung Carcinoma;
Stage II Squamous Cell Carcinoma of Lung;
Stage II Squamous Cell Carcinoma of the Lung;
Stage II Squamous Cell Lung Carcinoma =Neoplastic Process |
- 23. lung injury
- [lung damage due to exposure to chemicals, pathological process, external force, or other injurious event. ( CSP )] (UMLS (CSP) C0273115) =Injury or Poisoning =Lung Diseases;
injury | - 56. Lung Squamous Cell Carcinoma Stage III
- [Stage III includes: IIIA: (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0) IIIB: ( Any T, N3, M0); (T4, Any N, M0) N1: regional metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes including involvement by direct extension of the primary tumor. N2: Metastasis to ipsilateral mediastinal and/or subcarinal lymph node(s). N3: Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s). T1: tumor is 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, and without bronchoscopic evidence of invasion more proximal than the lobar bronchus. T2: tumor has any of the following features of size or extent: more than 3 cm in greatest dimension; involves the main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: tumor (of any size) directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, mediastinal pleura, parietal pericardium; or tumor in the main bronchus less than 2 cm distal to the carina but without involvement of the carina; or associated atelectasis or obstructive pneumonitis of the entire lung. T4: tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, carina; or separate tumor nodules in the same lobe; or tumor with a malignant pleural effusion. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C0854993) Stage III Epidermoid Cell Carcinoma of Lung;
Stage III Epidermoid Cell Carcinoma of the Lung;
Stage III Epidermoid Cell Lung Carcinoma;
Stage III Squamous Cell Carcinoma of Lung;
Stage III Squamous Cell Carcinoma of the Lung;
Stage III Squamous Cell Lung Carcinoma =Neoplastic Process |
- 24. LUNG INJURY NOS-CLOSED
- [ ] (UMLS (ICD9CM) C0160328) =Injury or Poisoning
| - 57. Lung Surfactant
- [phospholipids secreted by the great alveolar cells into alveoli and respiratory air passages which contributes to the elastic property of pulmonary tissue. ( CSP )] (UMLS (NCI) C0034085) =Lipid; Pharmacologic Substance; Biologically Active Substance =Lipoprotein;
phosphatide;
Body System, Pulmonary;
=1,2-Dipalmitoylphosphatidylcholine;
beractant |
- 25. LUNG INJURY NOS-OPEN
- [ ] (UMLS (ICD9CM) C0160332) =Injury or Poisoning
| - 58. Lung TAA
- [A tumor associated antigen derived from the cell surface antigen of lung cancer cells. Lung tumor associated antigen could be used as a diagnostic marker or as a form of immunotherapy targeted against lung cancer cells. ( NCI )] (UMLS (NCI) C0796687) Lung Tumor Associated Antigen;
tumor associated antigen, lung =Pharmacologic Substance; Immunologic Factor |
- 26. LUNG INVOLV IN OTH DIS
- (UMLS (ICD9CM) C0155917) =Disease or Syndrome ;
| - 59. lung tryptase
- [E.C. 3.4.21.59. ( CSP )] (UMLS (CSP) C0147080) =Amino Acid, Peptide, or Protein; Enzyme =Serine Endopeptidases;
|
- 27. Lung involvement in conditions classified elsewhere
- (UMLS (ICD9CM) C0155915) =Disease or Syndrome ;
| - 60. Lung Upper Lobe
- [The lobe of the right lung that lies above the oblique and horizontal fissures and includes the apical, posterior and anterior bronchopulmonary segments; in the left lung, the lobe lies above the oblique fissure and contains the apicoposterior, anterior, superior lingular and inferior lingular segments. ( NCI )] (UMLS (NCI) C0225756) =Body Part, Organ, or Organ Component
|
- 28. Lung involvement in systemic sclerosis
- [ ] (UMLS (ICD9CM) C0339904) =Disease or Syndrome ;
| - 61. lung visualization
- [ ] (UMLS (CSP) C0920570) =Diagnostic Procedure
|
- 29. lung ischemia
- [ ] (UMLS (CSP) C0920711) pulmonary ischemia =Pathologic Function ;
| - 62. LUNG VOL REDUCTION SURG
- [ ] (UMLS (ICD9CM) C0375931) =Therapeutic or Preventive Procedure
|
- 30. lung ischemia/hypoxia
- [blood deficiency in the lungs caused by a constriction or obstruction of its blood vessels; frequently occurs in conjunction with hypoxia, which is reduction in oxygen supply. ( CSP )] (UMLS (CSP) C0596865) =Pathologic Function ;
=ischemia;
Lung Diseases;
respiratory hypoxia;
| - 63. lung volume
- [ ] (UMLS (CSP) C0231953) =Organ or Tissue Function
|
- 31. Lung Left Upper Lobe
- (UMLS (NCI) C1261076) Upper Lobe of Left Lung-LUL;
Upper Lobe of the Left Lung;
Upper Lobe of the Left Lung-LUL =Body Part, Organ, or Organ Component | - 64. lungfish
- [ ] (UMLS (CSP) C0599045) =Fish ;
|
- 32. Lung Lobe
- [One of the subdivisions of the lung, 2 in the left lung and 3 in the right lung. ( NCI )] (UMLS (NCI) C0225752) =Body Part, Organ, or Organ Component
| - 65. Lunula
- (UMLS (NCI) C0221991) =Body Part, Organ, or Organ Component
|
- 33. Lung Lymphangioleiomyomatosis
- [Lymphangiomyomatosis involving the lungs and local lymph nodes. Patients usually present with chylous pleural effusion. The clinical course is variable. Patients with resectable lesions usually have a favorable clinical outcome. Patients with diffuse lesions usually have a progressive clinical course. ( NCI )] (UMLS (NCI) C0349649) =Neoplastic Process
| |
home
